These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34629472)

  • 1. [Obesity - A Risk Factor for Psoriasis and COVID-19].
    Llamas-Velasco M; Ovejero-Merino E; Salgado-Boquete L
    Actas Dermosifiliogr; 2021 Jun; 112(6):489-494. PubMed ID: 34629472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.
    Gisondi P; Bellinato F; Chiricozzi A; Girolomoni G
    Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33276686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Brownstone ND; Thibodeaux QG; Reddy VD; Myers BA; Chan SY; Bhutani T; Liao W
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):881-885. PubMed ID: 32468230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Links between Obesity and Psoriasis: A Comprehensive Review.
    Barros G; Duran P; Vera I; Bermúdez V
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Knowledge on Psoriasis During the Covid-19 Pandemic.
    Kašnar AM; Jurić K; Franić A; Čeović R
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):99-105. PubMed ID: 36254542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for Systemic Treatment of Psoriasis in Obese Patients.
    Gisondi P; Del Giglio M; Girolomoni G
    Am J Clin Dermatol; 2016 Dec; 17(6):609-615. PubMed ID: 27411805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
    Sterry W; Strober BE; Menter A;
    Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of Inflammation in Obesity-Psoriatic Patients.
    Rodríguez-Cerdeira C; Cordeiro-Rodríguez M; Carnero-Gregorio M; López-Barcenas A; Martínez-Herrera E; Fabbrocini G; Sinani A; Arenas-Guzmán R; González-Cespón JL
    Mediators Inflamm; 2019; 2019():7353420. PubMed ID: 31275060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in patients with psoriatic disease.
    Gelfand JM; Yeung H
    J Rheumatol Suppl; 2012 Jul; 89():24-8. PubMed ID: 22751586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities.
    Yan T; Xiao R; Wang N; Shang R; Lin G
    Theranostics; 2021; 11(17):8234-8253. PubMed ID: 34373739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications.
    Carrascosa JM; Rocamora V; Fernandez-Torres RM; Jimenez-Puya R; Moreno JC; Coll-Puigserver N; Fonseca E
    Actas Dermosifiliogr; 2014; 105(1):31-44. PubMed ID: 23177976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and the role of chronic inflammation in patients with obesity.
    Chiappetta S; Sharma AM; Bottino V; Stier C
    Int J Obes (Lond); 2020 Aug; 44(8):1790-1792. PubMed ID: 32409680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review.
    Moreno-Fernandez J; Ochoa J; Ojeda ML; Nogales F; Carreras O; Díaz-Castro J
    J Physiol Biochem; 2022 Aug; 78(3):581-591. PubMed ID: 35316507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations.
    Cava E; Neri B; Carbonelli MG; Riso S; Carbone S
    Clin Nutr; 2021 Apr; 40(4):1637-1643. PubMed ID: 33765600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psoriasis, a systemic disease?].
    Puig-Sanz L
    Actas Dermosifiliogr; 2007; 98(6):396-402. PubMed ID: 17663929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Weight of Obesity in Immunity from Influenza to COVID-19.
    Andrade FB; Gualberto A; Rezende C; Percegoni N; Gameiro J; Hottz ED
    Front Cell Infect Microbiol; 2021; 11():638852. PubMed ID: 33816341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics for Psoriasis During the COVID-19 Pandemic.
    Zeng H; Wang S; Chen L; Shen Z
    Front Med (Lausanne); 2021; 8():759568. PubMed ID: 34938746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and COVID-19: A narrative review with treatment considerations.
    Elmas ÖF; Demirbaş A; Kutlu Ö; Bağcıer F; Metin MS; Özyurt K; Akdeniz N; Atasoy M; Türsen Ü; Lotti T
    Dermatol Ther; 2020 Nov; 33(6):e13858. PubMed ID: 32686245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management.
    Yang Y; Song Y; Hou D
    Diabetes Metab Syndr Obes; 2023; 16():4147-4156. PubMed ID: 38145256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.